$AVXL At this level, the remaining float could easily get locked up by institutional investors and they will likely come in the next days/weeks for this very high reward / low risk company.

There is close to zero risk for that.

$AVXL There is no risk of meeting the end points and safety and other unknowns or delays.

Worth the risk with patience and not investing lifestyle or bill money.

My risk is worth it if other pump.

From the perspective of long only DCA, risk reward here is significant. #nostoploss

Maybe worth paying more for lower risk.

I like the bet & risk:reward and the science, will make it every time (esp w/all house money at this point)🤷‍♂️

minimizes risk and allows for accumulation over time before the REAL money is made.

So this is the best risk to reward investment you will see in your lifetime.

25K shares isn't much of risk imo and this is a very very profitable company still wtf

The fact this is at no risk of another offering due to having enough capital to last until 2024 puts this in a special category of penny stocks.

Low risk high reward on this one.

Add to it the fact that the stock was shorted into the dirt, the upside potential is incredibly high without the usual risk seen in this size company.

$COSM is Shorts Favorite stock -5% -10% daily return no risk high reward -30%-40% a week

$COSM my money 💰 will raise and shine here with or without too greedy criminal bears .. they will learn … ctb around 100 percent…and lots of positive catalysts/ PR in front… near alltime lows the risks here are tiny as the float…

$COSM SSR Today amigos and Market will be bullish 🤣🤑 No risk, number one on fintel shorts squeeze.

Do your due diligence, I think you’ll find COSM a good risk / reward.

$GROM Low risk high reward!!!

From a business risk standpoint they are lower risk and in particular for a micro cap.

No long term SP risk and could easily go beyond 20 $ even if (conservative) sales predictions are just confirmed.

Doubled in size and reduced cash burn with no risk of dilution.

$ARDX With the dilution being announced and baked in now, there is no risk left here.

The risk here is GONE, and there are numerous catalysts coming this year.

but- Isbrela scripts have been growing consistently & I think the stock still warrants every bit of a $2.50-5.00 price based on growth and IBS-C market Imo still not a lot a lot of downside risk here even after a 100% 2 month gain.

Good risk return, because you can loose 0.7$ and the upside is 4x bigger. 13.

It’s the best way for me to hedge my risk exposure.

$ARDX Does Tanapanor’s benefits outweigh the risks? Yes.

• There are no risks that would deny approval of this product.

Do benefits outweigh risks.